Skip to Main Content

T Cell Role in the Pathophysiology of Heart Failure

December 21, 2021
  • 00:00So. Good afternoon everyone.
  • 00:03Thank you for attending a
  • 00:06year pathology gram one.
  • 00:07Sending a series.
  • 00:09It's our great pleasure to invite Doctor
  • 00:12Killer or Katie to speak at our grandma.
  • 00:16I met at scientific conferences and I'm
  • 00:19impressed by her outstanding mechanistic
  • 00:21research in immunology and cardiology.
  • 00:25Cloud received her pH D from the Autonomous
  • 00:28University of Madrid, Spain, she.
  • 00:31Performed her postal research
  • 00:33at Brigham Women Hospital,
  • 00:36have a medical school.
  • 00:37She studied her faculty position
  • 00:39as an assistant professor at the
  • 00:41Department of Medicine, Tufts University.
  • 00:43She has been attending
  • 00:45resources professor since 2019.
  • 00:47She's the program director of Immunology
  • 00:51graduate program is an endowed chemist,
  • 00:54and Joann,
  • 00:55where professor and the interim
  • 00:58vice chair of department
  • 01:00immunology at Tufts Class Group,
  • 01:03has made important discoveries in the
  • 01:05area of mechanism T cell trafficking.
  • 01:08Their research efforts are focused
  • 01:10on understanding why and how T cell
  • 01:14subsets and in gaseous interaction.
  • 01:16They also study intrinsic properties of
  • 01:19the vascular in the cilium that modulated
  • 01:22key cell and leukocyte recruitment
  • 01:24in the T cell trafficking and survival.
  • 01:27Another exciting line of risk in
  • 01:29class group is about inflammation,
  • 01:31heart failure to recent research has
  • 01:34contributed significantly to your paradigm
  • 01:37shift in understanding of heart failure.
  • 01:39Putting T cell inflammation as a measure
  • 01:42of player in this heart failure disease.
  • 01:46So exciting research program have
  • 01:49led to multiple impactful papers
  • 01:52such as circulation journal,
  • 01:53experimental medicine,
  • 01:54JCR inside a TVP and etc.
  • 01:58Pillars research has been has
  • 02:00been funded by NIH one brand.
  • 02:03She has also showed great leadership in
  • 02:06science by serving our editorial board
  • 02:08such as Junior Clinic investigation,
  • 02:10Fast, GMC and etc.
  • 02:14Additionally,
  • 02:15she has been serving the American Heart
  • 02:18Association during past many years.
  • 02:20She has been the HCA basic cardiovascular
  • 02:22Science program chair since last year.
  • 02:26Without further ado,
  • 02:27let's welcome Killer.
  • 02:28To give us her seminar entitled T
  • 02:31Cell Role in the passive Physiology
  • 02:33of heart failure, can I thank you?
  • 02:37Thank you very much.
  • 02:38You ring for the invitation.
  • 02:40It's really nice to be here and also
  • 02:44thank you to all those of you who
  • 02:48I've met with this morning because
  • 02:50I've returned your science because I
  • 02:52I've been really enjoying, you know,
  • 02:54all the things that you're doing here.
  • 02:56So as giving said,
  • 02:58I'm going to focus today's talk on the
  • 03:01aspect in the lab where we study the
  • 03:04role of T cells in the pathophysiology.
  • 03:07Of heart failure I have no disclosures
  • 03:11and basically this is a cartoon that
  • 03:14summarizes the general theme of our lab,
  • 03:17which is how the moon system impacts
  • 03:19cardiac and vascular health.
  • 03:21So as you being said,
  • 03:22I train in immunology and then I
  • 03:25further train in vascular biology,
  • 03:27but we know that immune cells
  • 03:31they really need to traffic into
  • 03:33tissues to do their functions.
  • 03:36But then once.
  • 03:37In addition,
  • 03:38they need to interact or crosstalk with
  • 03:42all the different resident cells in order
  • 03:46to modulate homeostasis or pathology.
  • 03:49In the case of injury.
  • 03:51So for today's talk,
  • 03:52I will focus on what we've been
  • 03:54learning recently in the lab from
  • 03:56our work and also from the work
  • 03:58of others of how this interaction
  • 04:01between adapted and innate immunity
  • 04:03contributes to cardiac remodeling.
  • 04:06In hard and I I place a circle
  • 04:10here because this is mainly where
  • 04:12these interactions between adapted
  • 04:14and it made immune cells happen.
  • 04:17This is what T cell antigen
  • 04:19recognition starts in the lymph nodes.
  • 04:22But towards the end of the talk I
  • 04:24will show some new data is still
  • 04:26unpublished where we really find that
  • 04:28they're very similar interactions
  • 04:29that are also happening in the
  • 04:31heart and that they might modulate
  • 04:34correct Physiology this way.
  • 04:36So as many of you probably know,
  • 04:38heart failure is very complex
  • 04:40and it's multifactorial.
  • 04:41So to tackle mechanisms,
  • 04:42we need to start in a simplistic way.
  • 04:46But we also need to understand
  • 04:48the full complexity.
  • 04:49So what do we know is that
  • 04:51regardless of the etiology,
  • 04:53whether it was triggered
  • 04:54by any ischemic event,
  • 04:56such as a myocardial infarct
  • 04:59or non ischemic event.
  • 05:01The heart remodels and the characteristics
  • 05:04of the failing heart are increased.
  • 05:07High level curricular pressures and
  • 05:11then a hypertrophic cardiomyocytes
  • 05:14fibrosis and these results in
  • 05:17systolic and diastolic dysfunction.
  • 05:19And we've known since the 50s that
  • 05:22systemic chronic inflammation
  • 05:23is associated with pretty much
  • 05:25all of the causes of all of the
  • 05:28etiologies of heart failure.
  • 05:30I'm just going to set up my timer
  • 05:32here to make sure that we're.
  • 05:33Runtime here.
  • 05:35But unfortunately this by this knowledge,
  • 05:37for many,
  • 05:38many years today none of the
  • 05:40anti-inflammatory therapies for clinical
  • 05:42trials that were initially launched
  • 05:44to tackle a pro inflammatory cytokines,
  • 05:47such as TNF.
  • 05:48And more recently,
  • 05:49with the counters trial
  • 05:51island bed and none of them,
  • 05:53this is the anti TNF therapies
  • 05:55that are very efficient in treating
  • 05:57out immune diseases and chronic
  • 05:59inflammatory diseases did not
  • 06:01work in heart failure and there
  • 06:04are more recent
  • 06:05promising data with the Cantor's trial,
  • 06:08although it's still early to tell
  • 06:10whether it has really benefited in in
  • 06:13some of the outcomes of heart failure.
  • 06:16So what we know is that there are no
  • 06:19anti-inflammatory antifibrotic therapies
  • 06:21that have been successful today,
  • 06:23and we know from many organ systems
  • 06:26that inflammation or immune cell
  • 06:29activation and fibrosis go together or
  • 06:32have some overlapping functions as well.
  • 06:35So the first question that we
  • 06:37asked several years ago was is,
  • 06:39is there cardiac information?
  • 06:41Besides systemic chronic inflammation
  • 06:43again going with the concept that if the
  • 06:46immune cells traffic to an inflamed issue,
  • 06:48do they exert their functions by
  • 06:51communicating with the tissue
  • 06:53or stroma cells?
  • 06:55And then if that was the case,
  • 06:57do the cardiac infiltrated muscles
  • 06:59contribute to the hallmarks
  • 07:00that we see of heart failure,
  • 07:02such as correct fibrosis?
  • 07:03And does that have any impact
  • 07:05on cardiac dysfunction?
  • 07:06And obviously we're very interested as
  • 07:10basic scientists in understanding how.
  • 07:13So the first experiment that we did
  • 07:15this this is this was published.
  • 07:16This is back in 2015,
  • 07:19but we wanted to say whether we
  • 07:22could see cardiac inflammation
  • 07:24in patients with heart failure,
  • 07:25but we wanted to look at patients
  • 07:28with non ischemic heart failure.
  • 07:29Antonio Barish group at VCU in Virginia.
  • 07:33He had elegantly demonstrated
  • 07:34years before this that in response
  • 07:36to myocardial infarction,
  • 07:38there was decent infiltration in
  • 07:40the human heart and interestingly.
  • 07:42The diesels were infiltrated in the
  • 07:46in the scar zone in the infarct zone,
  • 07:49but also,
  • 07:50so that goes along with a roll of
  • 07:53the immune system during evolution
  • 07:55to help healing.
  • 07:57But interestingly,
  • 07:58what they had found in inference
  • 08:00was that there were also a lot of T
  • 08:02cells infiltrated and remote zones.
  • 08:04So we thought if we chose a patients
  • 08:06that did not have any impact that have
  • 08:08sort of like low chronic inflammation,
  • 08:11where we see these as infiltrated
  • 08:12in the heart.
  • 08:13And this is exactly what we found
  • 08:16here in Brown that they end stage
  • 08:18nonischemic heart failure and
  • 08:20heart samples which were taken as
  • 08:22stated here from from there had
  • 08:26significant diesel infiltration.
  • 08:28Compared to non heart failure controls.
  • 08:31And later on we did some experiments
  • 08:33where we also wanted to look at what
  • 08:36kind of pistols were infiltrated there,
  • 08:38and we found that many of those
  • 08:41teachers expressed the chemo keen
  • 08:43receptor CXCR 3 and this is shown here
  • 08:46by Red Arrows and quantified here.
  • 08:49So this this made the basis to
  • 08:52wanted to understand mechanistically
  • 08:54what is thesis that expressed these
  • 08:57receptors are doing within the heart.
  • 09:01So our very broad hypothesis.
  • 09:03110 and Evers joined my lab as
  • 09:06postdoc was asking the question,
  • 09:08is this purely an association or
  • 09:10are they actually contributing or
  • 09:12doing something in the heart and her
  • 09:15hypothesis was that they would be
  • 09:16doing something there in the failing heart?
  • 09:20And to start doing this we have to
  • 09:23choose a preclinical model and knowing
  • 09:25that heart failure is very complex,
  • 09:27there's no optimal or perfect.
  • 09:31The clinical model that mimics
  • 09:33all the symptoms of heart failure
  • 09:36or how the disease develops,
  • 09:38but we found that for nonischemic
  • 09:40heart failure tack or transverse or
  • 09:43reconstruction was a one where we could time,
  • 09:47and for certain reasons,
  • 09:48that we wanted to do.
  • 09:49It was really a very good model to do so.
  • 09:52Why? Because it induces pressure
  • 09:54that mimics the pressure that heart
  • 09:56failure patients have in the heart.
  • 09:58Although the downside is that here.
  • 10:01It induces a sudden pressure that then
  • 10:04is restrained versus impatience as
  • 10:06we know they developed progressively,
  • 10:08but importantly,
  • 10:09in this model we can basically track very
  • 10:13nicely how cardiac hypertrophy develops,
  • 10:15how cardiac fibrosis develops,
  • 10:17and whether we can check in per cardiac
  • 10:20function and at those time points.
  • 10:22We could also look for diesel immune
  • 10:25responses and correct diesel infiltration.
  • 10:27So using this model I'm showing data
  • 10:30from 4 weeks. Play time points.
  • 10:32That is all summarizing schematics.
  • 10:35Because we published this already.
  • 10:38But what we found was that it
  • 10:40specifically one type of thesis
  • 10:42that are CD 4 positive T cells
  • 10:45were infiltrated in the heart as
  • 10:46early as two weeks post stack.
  • 10:48And this is four weeks after Tak.
  • 10:51And then,
  • 10:51before they infiltrated in the heart,
  • 10:54we saw a significant expansion of the
  • 10:56medicinale draining lymph nodes that are
  • 10:58the lymph nodes that drain the heart.
  • 11:00And most of those T cells express
  • 11:03interferon gamma so they were type
  • 11:06one TT cells T H1 cells which also
  • 11:09expressed the chemokine receptor.
  • 11:116 year 3.
  • 11:13And then we found that these
  • 11:16infiltration was associated with at the
  • 11:18time where mice developed fibrosis.
  • 11:20As you can see here in pink,
  • 11:21the collagen deposition and enlargement
  • 11:24of the cardiac myocytes by H&E.
  • 11:27And what we found using this mouse
  • 11:30model was that if my eyes were
  • 11:33genetically deficient in D zones
  • 11:34and we use different models,
  • 11:36diesel receptor alpha Nokia or MHC 2
  • 11:39knockout or right to knock out what
  • 11:42we found was that all the mice that
  • 11:44did not have decent genetically they
  • 11:47did not develop a cardiac fibrosis.
  • 11:49We cannot see any College in
  • 11:51the position here.
  • 11:52And then when these mice were reconstituted,
  • 11:54we see Excel 3 positive there
  • 11:56from gamma positive.
  • 11:57Keystones we could partially
  • 12:00reconstitute the fibrosis.
  • 12:01Certainly the provascular fibrosis.
  • 12:03As you can see here,
  • 12:05and we could reconstitute and or
  • 12:07a lot of the cardiac dysfunction.
  • 12:09Although this data also suggested
  • 12:12that there had to be some cardiac
  • 12:15antigen specificity involved to
  • 12:17to induce the full induction of
  • 12:19cardiac fibrosis and dysfunction.
  • 12:21In these experiments, as I said,
  • 12:23we reconstituted fibrosis,
  • 12:25some parameters of systolic
  • 12:27and diastolic dysfunction.
  • 12:29But these cells that we put
  • 12:31back into these mice,
  • 12:33they were highly painful.
  • 12:35Amatory but not antigen specific and
  • 12:37this will link to the second part of my
  • 12:41talk and why that might be important.
  • 12:43How we can use that in in in to
  • 12:47understand this complex syndrome.
  • 12:50So the other thing that I needed
  • 12:52was well now
  • 12:52that we know that these T cells that express
  • 12:55in there from gamma are increasing the
  • 12:58lymph nodes under infiltrated in the heart.
  • 13:02How can we see if they actually cross
  • 13:05communicate with a cardiac residents?
  • 13:07Because we saw that massive
  • 13:09effect on cardiac fibrosis.
  • 13:11We see it was a simple
  • 13:13experiment to start with,
  • 13:14which was isolating primary,
  • 13:16correct fiberglass from Adele mites
  • 13:18and then see isolated T cells.
  • 13:21From the mediastinal lymph nodes of
  • 13:23mice that were subjected to either sham,
  • 13:25so control surgery,
  • 13:27I should say that some might have the
  • 13:30the open chest surgery and everything
  • 13:33except for the construction to
  • 13:36account for possible inflammation
  • 13:38that happens during surgery.
  • 13:40I know what you did is the Chico
  • 13:43culture this and then she she
  • 13:45coculture this indirect cultures or
  • 13:47entrance once and the idea was that
  • 13:49first he was going to see whether
  • 13:51these teasers could adhere to the
  • 13:54fibroblast and whether these fiberglass
  • 13:56transform to myofibroblast and to
  • 13:58do the readout for myofibroblast.
  • 14:01We looked at alpha small muscle
  • 14:04acting which is expressed upon
  • 14:07fiber restaurants formation.
  • 14:09So in those experiments,
  • 14:11this is a representative image.
  • 14:13You can see that a direct contact was
  • 14:15required for these transformation,
  • 14:17so these are two examples of
  • 14:20transform my fiberglass that have
  • 14:21a lot of T cells bound to them.
  • 14:24The T cells were labeled in in green here
  • 14:27and this is the quantification of the
  • 14:31of of the red of alpha small muscle acting.
  • 14:35So the conclusion from these
  • 14:37experiments was that there was
  • 14:38these communications between.
  • 14:40Pieces of fiberglass that was required
  • 14:43to induce transformation and then a
  • 14:46mechanistically what we found was
  • 14:48that this was TGF beta dependent,
  • 14:50so it will block TGF beta.
  • 14:52We inhibited this transformation that
  • 14:54was not too surprising because we know
  • 14:57that PDF better was it's a classic
  • 15:00profit garlic cytokine that induces.
  • 15:03This transformation and that is
  • 15:05highly made by my fiberglass as well,
  • 15:07but what was more interesting is
  • 15:09that we found that T cells bound to
  • 15:12the fiber rest through A4 integrin,
  • 15:14and we come one in the fiberglass
  • 15:16and then once bound,
  • 15:18the diesels were induced and DJ better
  • 15:21released by the myofibrils are not
  • 15:23the other way around and this was also
  • 15:26published so I wouldn't show a lot
  • 15:28of the data there so I can focus on
  • 15:30more recent data in in our lab as well.
  • 15:33We're currently working on on
  • 15:36further mechanistic insight
  • 15:37into how we can prevent this.
  • 15:40They released induced by the FIBERLESS
  • 15:43upon the contact with the discus.
  • 15:46So as a summary of background of
  • 15:48why we became interested in this,
  • 15:50we can see that in this transformation
  • 15:53from the healthy heart to the failing
  • 15:55heart using an experimental model,
  • 15:57in this case of transverse article
  • 16:00struction visit this activation,
  • 16:02particularly of this T cell subset.
  • 16:05And then we say that these are traffic
  • 16:07to the heart and once in the heart.
  • 16:09They crossed off with a fiberglass
  • 16:11and induced cardiac fibrosis.
  • 16:13We block these by either using
  • 16:16agent mice that don't have T cells,
  • 16:19or by using depletion diesel
  • 16:21antibodies in wild I'm eyes.
  • 16:23I didn't show the data by the way.
  • 16:25We also did those studies.
  • 16:27We prevent this transformation.
  • 16:30We also found that the characters
  • 16:35themselves they in response to
  • 16:37pressure in response to duck even
  • 16:39before the T cells get there,
  • 16:42they can actually make chemokines that
  • 16:45Kim attracts positive T cells and we
  • 16:47did this using a reported mice for
  • 16:50these schemes and and doing a time course.
  • 16:53So we actually found that the
  • 16:56fiberglass are actually functioning
  • 16:58as a semi immune cell because
  • 17:00they're releasing chemokines.
  • 17:01Then they end up attracting first my
  • 17:04load cells and then T cells to the heart,
  • 17:07and then as I just showed,
  • 17:09we found that they can regulate
  • 17:12correct for groceries.
  • 17:13So then when I question that we asked
  • 17:16was well how and where this is being
  • 17:19activated in the heart and this work
  • 17:22was done by Jay Wanyama who was a
  • 17:25graduate student in the lab and he
  • 17:27was really interested in knowing
  • 17:29this because he found he said well,
  • 17:31if we found a specific antigens that might
  • 17:34be relevant for the T cell immune response.
  • 17:37Then one could think about in
  • 17:39this in the future.
  • 17:40Potentially immunizing for heart failure,
  • 17:43right?
  • 17:44There will be a long term goal or at
  • 17:47least understanding whether this is
  • 17:50what was this this activation happening
  • 17:53and where over time it could be prevented?
  • 17:57So to study that we use a reporter
  • 18:00mice for T cell activation or
  • 18:03T cell receptor engagement.
  • 18:05So these are in order to be activated
  • 18:07by antigen presenting cells,
  • 18:09they need to recognize antigen,
  • 18:11and in the case of CD 4 positive T
  • 18:13cells they express the diesel receptor
  • 18:16here and then dendritic cells.
  • 18:18Are they the main antigen presenting
  • 18:21cells express MHC two and they
  • 18:24can capture antigen and induce T
  • 18:27cell receptor signals and these
  • 18:30reporter mice mimic.
  • 18:32They're basically reporters
  • 18:33of diesel receptor engagement.
  • 18:35So the green are the cells are because
  • 18:39they express N 77 which is downstream.
  • 18:42The diesel receptor bound to GFP.
  • 18:45So the greener the cells are.
  • 18:47That's telling you that
  • 18:48they're recognizing antigen.
  • 18:49This expression is also transient,
  • 18:53so if we see green cells,
  • 18:56it means that at the time where
  • 18:58we're harvesting those cells,
  • 18:59they're recognizing antigen.
  • 19:00But it might be that they recognize
  • 19:03antigen and then they're not recognizing.
  • 19:06Antigen at that point and then
  • 19:08they lose expression.
  • 19:09So in order to look at this,
  • 19:11we basically did the time course
  • 19:13of tag again early on,
  • 19:15where is compensatory changes and then
  • 19:18once is systolic dysfunction is established,
  • 19:21and then we kept them for longer.
  • 19:23That will mimic more chronic heart
  • 19:26failure and what we did is we harvested
  • 19:29the hearts and the medicinal influence.
  • 19:32And the first thing that we did here.
  • 19:35And we found that was very,
  • 19:37very surprised,
  • 19:38surprising,
  • 19:39and the most interesting finding.
  • 19:41I I I felt from from this story that we
  • 19:44recently published was that we saw
  • 19:46this T cell receptor engagement not
  • 19:48only in the cardiac lymph nodes,
  • 19:50but also within the heart.
  • 19:53And as you can see here,
  • 19:54you said the very bright GFP
  • 19:57cells that increase overtime.
  • 19:59So that's telling us that once
  • 20:01the T cells infiltrate the heart,
  • 20:04they must be vendrick cells.
  • 20:06And potentially other cells that
  • 20:08capture the antigen and induce
  • 20:10decent expansion within the heart
  • 20:12and that would be bypassing the the
  • 20:14final trafficking that you need from
  • 20:16the lymph node into into the heart.
  • 20:19So we quantify this and as you can see,
  • 20:22there's a significant increase of
  • 20:25GFP positive active T cells in
  • 20:28the heart that correlates with
  • 20:30decline in systolic function.
  • 20:32Measure here with fractions.
  • 20:35So if we go back to how this teaser
  • 20:38activation happened in the timers,
  • 20:41we have a lot of high T cell
  • 20:45receptor clonal diversity because our
  • 20:48diesels are deciding what you know,
  • 20:52depleting what's against self antigens
  • 20:54and selecting for what we might
  • 20:57need in the future if we get closer
  • 20:59to the high in the Middle East and
  • 21:01lymph node we will have the selected
  • 21:03a pool of clones that will get expanded.
  • 21:05If there is any immune response
  • 21:07and then the question was what
  • 21:09we were seeing in the heart,
  • 21:10so our data using these reporter
  • 21:13found that indicated that there was
  • 21:15this expansion in the correct running
  • 21:18lymph nodes as well as in the heart,
  • 21:20and then we decided to do this
  • 21:22receptor sequencing to get a closer
  • 21:24look at whether these T cells or
  • 21:25whether it might be recognizing.
  • 21:27So this is the structure of the
  • 21:29T cell receptor.
  • 21:29Many of you probably know,
  • 21:31but just as a brief reminder
  • 21:32it has two Chainz,
  • 21:34the alpha and the beta chain.
  • 21:36And then they recombine in many
  • 21:38different ways to form a specificity.
  • 21:41Or these pocket to many different antigens.
  • 21:43So by sequencing this Cdr three region,
  • 21:47which is where these two chains
  • 21:50get closer and form the pocket
  • 21:53for antigen recognition,
  • 21:54we could get a sense of whether we
  • 21:56get in many different clones which
  • 21:59will indicate high clonality and not
  • 22:01not really an antigen specificity.
  • 22:03There was anything in the heart,
  • 22:05or whether we get.
  • 22:08Enrichment so the results that
  • 22:10we found was as expected.
  • 22:11There was a lot of clones,
  • 22:13many different diesel receptors
  • 22:15sequences in the timelines.
  • 22:18These are the inguinal lymph nodes and
  • 22:20again we have a high clonal diversity
  • 22:22and what we found was that the
  • 22:24closer that we were getting to the heart.
  • 22:27There more the decreased number
  • 22:29of total clothes that we found,
  • 22:32and the highest enrichment of the
  • 22:35top 20 most represented groups.
  • 22:37So today's my zaveri complicated
  • 22:40analysis and we found that there was
  • 22:43a restricted clonal pool in the heart
  • 22:45and that the majority of the cells
  • 22:47were represented by top 20 clones.
  • 22:49So we started diving more into
  • 22:51what this could be.
  • 22:53So what are these enrich
  • 22:55clones responded to in the
  • 22:56hunt and this will be the working month.
  • 22:59We know that this is happening and
  • 23:01then we know that there's this close
  • 23:04being expanded and what could those be?
  • 23:06So we ended up focusing on Russ and then
  • 23:10again because of the time limitation.
  • 23:13I'm not going through
  • 23:14everything that we went through,
  • 23:16but it basically one hypothesis was
  • 23:18that you could have a cardiomyocyte
  • 23:20proteins right that the myocytes die,
  • 23:23and then the fragments are picked
  • 23:26up by adding percentage selves.
  • 23:29But it turns out that in the attack
  • 23:30model and like in response to my
  • 23:32kardelen function where you see a lot
  • 23:34of cell damage in the attack model.
  • 23:37We don't see significant salvage early
  • 23:39on and even later on at four weeks.
  • 23:42But what we do see is high increases of
  • 23:46intramyocardial reactive oxygen oxygen
  • 23:49species which are labeled here in green.
  • 23:53So we went back to literature and we
  • 23:56hypothesized that maybe Rose could modify
  • 23:58correct proteins that then form new
  • 24:01antigens that are listed AT cell response.
  • 24:04Why do we?
  • 24:05Why would do we think that
  • 24:07there was a hypothesis?
  • 24:09It was because similar mechanisms
  • 24:11had been described in the vasculature
  • 24:13in the context of hypertension,
  • 24:15where there was this formation of ice level.
  • 24:19Glenda Lynn's,
  • 24:20which are highly reactive intermediates by.
  • 24:24Lipid peroxidation.
  • 24:25That then can adapt to self proteins
  • 24:27and create these new antigens.
  • 24:29So we contacted the people who had
  • 24:32done the scientists that had done this
  • 24:36very interesting research hypertension
  • 24:38David Harrison and Annette Kirabo,
  • 24:40and this started a beautiful
  • 24:42collaboration in which we were able
  • 24:45to test this hypothesis in the heart.
  • 24:48So basically we obtain a lot
  • 24:50of reagents from their labs,
  • 24:51and the first thing that we wanted
  • 24:53to know is whether this matter
  • 24:55in the human heart.
  • 24:56So we went back or human heart failure
  • 24:59sections and we use this one day 11 which
  • 25:02is an antibody that recognizes proteins.
  • 25:05Modified biologist was given to us
  • 25:08by David and Annette and as you
  • 25:11can see here we saw significant
  • 25:13recognition in three different
  • 25:16heart failure patient samples.
  • 25:18And no signals in a non
  • 25:21heart failure patient.
  • 25:22We went back to the marsh model and in
  • 25:24the marsh model we went back to these
  • 25:27reporter my cells and T cell recognition.
  • 25:31And we used the D1DD11 antibody
  • 25:35that recognizes proteins
  • 25:37modified by strategies in mouse.
  • 25:39This was a different version of the antibody.
  • 25:42And then they also send us some ISO
  • 25:45so they can generate and I soils LG
  • 25:50scavengers that could be used in in mice.
  • 25:54So how does it work with experiments in tack?
  • 25:57And then this is the structure
  • 25:59of the eye surgeons calendar,
  • 26:00and this is the control peptide.
  • 26:02So the two Joba that I'll be
  • 26:04showing is one with coverage.
  • 26:06Those rose reactive proteins and then
  • 26:09we tracked this activation and T
  • 26:13cell receptor engagement over time.
  • 26:15In some experiments we use tempo
  • 26:18because it's an antioxidant,
  • 26:20so it works upstream of the of the.
  • 26:24Draws formation so just to make it
  • 26:27simpler in for understanding the idea,
  • 26:31this is a question that we were trying
  • 26:33to ask and the idea is that in response
  • 26:36to diagnose Ross and then this Ross
  • 26:38induces the formation of this lipid
  • 26:41peroxidation and this ISO, geez,
  • 26:44that then they adapt to a cardiac protein.
  • 26:47I'm from Disneyland pigeons that could
  • 26:49be taken by the dreaded cells and
  • 26:52being presented these cells to induce
  • 26:55T cell activation and proliferation.
  • 26:57So we could block these with temple perhaps.
  • 27:00And if we block this, if this was true,
  • 27:03maybe we would see less this
  • 27:05activation or proliferation in heart.
  • 27:07And if you block this with the
  • 27:10ISO G specific scavenger,
  • 27:12we could potentially block this and
  • 27:13block this activation in the heart,
  • 27:15and then of course the final question was,
  • 27:17will this have any impact incorrect function?
  • 27:22So the first thing that we did is we
  • 27:24did those experiments in mice and then
  • 27:27we isolated and Rick cells from mice
  • 27:29treated with these AI soldiers scavengers.
  • 27:32And as you can see here,
  • 27:34this is the antibody that detects
  • 27:36the isolated protein adducts.
  • 27:38And as you can see with the four coma,
  • 27:41which is the control and the
  • 27:44control compound,
  • 27:45we see that in drink cells
  • 27:47express this and take a protein.
  • 27:49But this is significantly
  • 27:51inhibited when we scavenged.
  • 27:55And then when we look directly in the House
  • 27:57looking for teachers using the reporter mice,
  • 27:59we found that only in those miles that
  • 28:02were treated with the iceberg scavengers,
  • 28:05we were able to significantly decrease
  • 28:08this teaser activation within the heart.
  • 28:11This is again GFP,
  • 28:12because this underreported mines and
  • 28:14I don't think I mentioned it earlier,
  • 28:16but this is this receptor beta
  • 28:18to make sure that we're focusing
  • 28:20on the right distal population.
  • 28:23So then how can OK?
  • 28:25So now we know that under excels pick it up,
  • 28:28but added functional inducing
  • 28:30diesel proliferation.
  • 28:32Here we found that there's
  • 28:35less this activation,
  • 28:36so the hypothesis is that when
  • 28:38these are become activated,
  • 28:39then they have to proliferate.
  • 28:42So we tested this hypothesis ex vivo
  • 28:45and we took the genetic cells from
  • 28:48control mice and loaded them with either
  • 28:51ice or GS or with a correct license
  • 28:54that were taken from the tag mice.
  • 28:58And then we coculture this and Rick
  • 29:00cells that were incubated with these
  • 29:02characteristics with teachers that
  • 29:04came from medicinal lymph nodes
  • 29:06from either sham or tag mouse.
  • 29:09And again we were trying to
  • 29:11mimic these response.
  • 29:12And after four days we can
  • 29:14look at T cell proliferation.
  • 29:17So the way we look at T cell proliferation
  • 29:19is because the teachers are labeled
  • 29:21with a membrane guide that is CFC.
  • 29:23And if they proliferate as you can
  • 29:25see here to see if you see a die is
  • 29:29diluted and this is just one example.
  • 29:32If we combine some T cells with sham lysates,
  • 29:37there's no proliferation,
  • 29:38and if you put tactics so there's
  • 29:41significant proliferation.
  • 29:43But basically what we found here,
  • 29:45this is only a representative experiment.
  • 29:47Everything is quantified in the manuscript.
  • 29:50But what we found was that only when
  • 29:53the teachers came from mice with
  • 29:56experimental heart failure and the
  • 29:58proteins that cells were loaded with
  • 30:01cardiac proteins that came from Tak
  • 30:04only this combination is when we
  • 30:06were able to see these new antigen
  • 30:10presentation and decent proliferation.
  • 30:12So did this have any impact in
  • 30:15cardiac function?
  • 30:15And these are echoes done
  • 30:17by our collaborators.
  • 30:19That Medical Center Rob Landon,
  • 30:21who is a cardiologist that whom I've
  • 30:24I've been collaborating with for many,
  • 30:27many years,
  • 30:27and what we found is that
  • 30:29these attack animals.
  • 30:31You can see the flat line here and
  • 30:34decrease historic function that is,
  • 30:37is quantified here.
  • 30:39Fractional shortening and
  • 30:40the harsh from the two hobas.
  • 30:42For them I struggle with this.
  • 30:43Lavender it were very healthy
  • 30:46compared to to the control.
  • 30:51So to summarize this part,
  • 30:53what we found was that in response
  • 30:55to high level trickler pressure.
  • 30:58There was a significant induction of
  • 31:01intramyocardial rose in the heart
  • 31:03and ended in Derrick cells that are
  • 31:06here are picking up some of the
  • 31:09of the proteins that are modified
  • 31:11by brass induced eye surgeries.
  • 31:14And then in the lymph node,
  • 31:15we saw that these T cells respond
  • 31:18to antigen and expand and then
  • 31:20they can go back to the heart.
  • 31:22And traffic to the heart.
  • 31:23But perhaps what was more intriguing
  • 31:26to us was that once in the heart.
  • 31:29You sometimes bypass this later on
  • 31:32within the heart because they can
  • 31:34actually recognize antigens within the
  • 31:37heart and be expanded there under.
  • 31:40This has significant effects
  • 31:42on cardiac fibrosis.
  • 31:46And I I didn't show the kind of
  • 31:49fibroglandular also had significantly
  • 31:51decreased fibrosis and this is going
  • 31:53to become more relevant for the next
  • 31:56part of the talk where I will be
  • 31:59talking about this critical antigen
  • 32:01recognition that happens in heart.
  • 32:04So for the last part of the talk,
  • 32:08then we I will focus about these kids
  • 32:12are correct fibroblast crosstalk.
  • 32:15So as I showed in the first part of the talk,
  • 32:17when the diesels Infiltrator hi,
  • 32:19this is an image ex vivo.
  • 32:21So these are fiberglass and culture
  • 32:23with T cells and you can see the
  • 32:26green cells are here and the blue
  • 32:29little nuclei of the diesels and
  • 32:31this is a large nuclei of fiberglass.
  • 32:33So we had found that with the diesels,
  • 32:37either DH one cells that were
  • 32:39generated extra evil or T cells
  • 32:42isolated directly from TAC mice.
  • 32:44They bound to the fiberglass
  • 32:46and once they bound they induce
  • 32:48the transformation to alphasim
  • 32:518 producing correct fiberglass.
  • 32:53And then in in the second part of
  • 32:55the talk I just recently showed you
  • 32:58that I didn't present themselves
  • 32:59and particularly in lyrics.
  • 33:01Elves present antigen to T cells
  • 33:04and there is this intramyocardial
  • 33:07diesel receptor engagement.
  • 33:10So then we we thought,
  • 33:11well,
  • 33:11they're not that many dendritic cells
  • 33:13in the heart as compared to other cells,
  • 33:16right?
  • 33:16Is it possible that during this T cell,
  • 33:20fiberglass crosstalk not only the T cells
  • 33:23are telling the fiberglass to to induce TGF,
  • 33:27beta and transform?
  • 33:28But maybe the fiberglass because diesels
  • 33:31are firmly adhered to the fiberglass.
  • 33:34Maybe the fiberglass may be functioning
  • 33:37as also an antigen presenting
  • 33:39cell that is semi professional.
  • 33:42So we went back to literature,
  • 33:44and in this there's this growing
  • 33:47field of struggle immunology,
  • 33:48where the concept is that antigen
  • 33:51presentation is no longer an
  • 33:53exclusive domain for the lyrics.
  • 33:55Also obviously then Derek cells
  • 33:57are antigen professional antigen
  • 34:00presenting cells,
  • 34:01but they're also evidence that
  • 34:03a stronger cells that support
  • 34:05tissue architecture can serve as
  • 34:08antigen presenting cells.
  • 34:09Depending on the context.
  • 34:11So this is an.
  • 34:13In an example of fibroblastic
  • 34:15particular cells in the lymph nodes.
  • 34:18Timing is stomach cells can do that as well.
  • 34:21There.
  • 34:21There are many reports that
  • 34:22show that two more infiltrated
  • 34:24fiber blasts do that as well,
  • 34:26and it's also a recent report in
  • 34:28the Lang where Lang epithelial cells
  • 34:30in the context of inflammation,
  • 34:32can actually present antigen
  • 34:35to certain diesels.
  • 34:37So we hypothesize that cardiac
  • 34:39fibroblasts may be functioning as antigen
  • 34:42presenting cells, and that these.
  • 34:45T cell receptor engagement that we
  • 34:47were seeing in the heart was not
  • 34:50exclusively due to the dirt excels,
  • 34:52but also to cut fiber breads.
  • 34:54And a wind.
  • 34:55Emma let this work and then called it cower.
  • 34:58In my lab was also contributed
  • 35:01significantly to this project.
  • 35:03So to remind you what an antigen
  • 35:05presenting cell in order to be an
  • 35:07antigen presenting cell as poor
  • 35:09as an indirect cell.
  • 35:10You need to efficiently internalize
  • 35:13and process antigens.
  • 35:15You need to display them
  • 35:17bound to MHC 2 molecules.
  • 35:20And then you have to present
  • 35:22that at the cell surface and
  • 35:24professional Apcs and Rick cells
  • 35:26constitutively express all of these.
  • 35:29MHC do is constantly expressed and then
  • 35:33these costimulatory molecules CD80 or
  • 35:36CD86 that are induced upon stimulation.
  • 35:41So we started investigating whether correct,
  • 35:44fabulous may fit into this category.
  • 35:47So this is a way that we select correct
  • 35:50fibrous in the heart with digest the hearts,
  • 35:53and then then we acquire this
  • 35:56and all the non fraction.
  • 35:58We're having the filial cells.
  • 36:01We'll have local sides and we have
  • 36:04a correct fiberglass here here.
  • 36:06Sorry so we have leukocytes here.
  • 36:093045 positives City 31 positive and
  • 36:12killer cells within the local sides
  • 36:15you could look for any local side that
  • 36:18you're interested in and within the
  • 36:20double negatives not in the filling.
  • 36:22No leukocytes.
  • 36:23We use these marker to detect
  • 36:26a cardiac fiberless mask 4.
  • 36:29We also do this in Linux reporter mice,
  • 36:33and that's where is indicated here.
  • 36:35So these are Linux tracing mice
  • 36:38where we could more more definitely
  • 36:40get into the cardiac fiberless.
  • 36:43So the first thing that we did is do
  • 36:45they express MHC two and a baseline?
  • 36:48They don't.
  • 36:48But as soon as you activate them with
  • 36:52interferon gamma you induce expression
  • 36:55of MHC two and actually in the filling
  • 36:57search for instance by people here
  • 36:59at nearly the department of Pathology,
  • 37:01German Barber,
  • 37:02and others found that endothelial cells
  • 37:05can present antigens to T cells as well,
  • 37:09and they respond and express MHC two
  • 37:11in response to interferon gamma.
  • 37:12So this would be a.
  • 37:14It's similar mechanism of expression.
  • 37:17And then what we found it was
  • 37:19that they do express customer
  • 37:20little molecules that you need to
  • 37:22trigger that diesel activation.
  • 37:24They do express CD 80 and
  • 37:27is not further inducible,
  • 37:29induced by different comma but
  • 37:32they don't express 86.
  • 37:34We collaborated with Jenn Davies and
  • 37:36their impact grad student in her
  • 37:38lab at the University of Washington
  • 37:40and exactly the same experiments
  • 37:42using the Linux trace in mice.
  • 37:44That is a reporter for correct fiberglass,
  • 37:47as shown in here.
  • 37:49And as you can see here,
  • 37:50all the correct fibers that are shown here.
  • 37:53The majority of them in response to it there,
  • 37:55from gamma, they express MHC 2 here in red,
  • 38:00so this is GFP and this is no inter
  • 38:03from gamma. With their from them.
  • 38:07Does this matter in vivo?
  • 38:08So in vivo we did pack and we found
  • 38:11that carrot fiberglass isolated from
  • 38:14from this report device expressed
  • 38:18MHC 2 and you can see it here.
  • 38:21You can focus here and this is zoom vision.
  • 38:24So this will be all in green.
  • 38:27Are cardiac fibrosis and as you can
  • 38:29see there are also other cells that
  • 38:31could be in the filler cells in a
  • 38:33small kappel Aries or the drink cells
  • 38:35as we previously shown that Expressen EC2.
  • 38:37I've been here.
  • 38:39Definitely,
  • 38:39the correct fiberglass are expressing MHC
  • 38:43two in response to tech as well.
  • 38:45And sometimes if you look you can find
  • 38:48that T cells seem very close to this
  • 38:52MHC 2 expressing correct fiberglass.
  • 38:54We use all the models of cardiomyopathy
  • 38:58and cardiac inflammation to see
  • 39:00whether this was unique or not,
  • 39:02and we used the tickers eye infection
  • 39:05model of myopathy because we know
  • 39:07that because I is a parasite,
  • 39:10I didn't use his highly strong
  • 39:12in there from gamma responses,
  • 39:14and as you can see here in this model,
  • 39:16the correct fabulous also expressed
  • 39:18any todo and more more of them
  • 39:21express MHC do and then at the MFA.
  • 39:25The prizes and densities also higher.
  • 39:29So then the next question was,
  • 39:31well, let's see if they can.
  • 39:34Take up the antigen processor and
  • 39:36present that induce T cell proliferation
  • 39:39and to do that we use a reagent that
  • 39:42is do DQ of album and so this is a
  • 39:45novel women protein that can be taken
  • 39:48up by proteins and if it goes in the
  • 39:51lysosomes with acidic lysosome pH,
  • 39:53which is what you're required to
  • 39:56process antigens it costs related
  • 39:58degradation and becomes for S.
  • 40:00And as you can see here,
  • 40:02regardless of the interference.
  • 40:04Treatment DQ over is processed
  • 40:06by cardiac fibroblast.
  • 40:08This is just one example of correct
  • 40:11fiber rest treated with equal woman,
  • 40:13but you can see here the comparison
  • 40:15of a large correct fiberglass
  • 40:17and obviously a smaller in size.
  • 40:19Here the bone marrow derived
  • 40:21cells that a process.
  • 40:24So that was very exciting too,
  • 40:26because then that means that
  • 40:28if they're able to process it,
  • 40:30they might be able to load it into MHC
  • 40:33two and induce decent proliferation.
  • 40:35So we did similar studies as
  • 40:37what I showed before to to look
  • 40:40for diesel proliferation,
  • 40:41and we use in this case we use
  • 40:44transgenic mice that are what they do,
  • 40:46so these mice all the T cell
  • 40:48receptors in the details express
  • 40:50a receptor for available mean.
  • 40:53And then we took this specific piece
  • 40:56of argument and then on the other hand,
  • 40:59we took it a wild diaper.
  • 41:00Makes you do knockout.
  • 41:01Correct fiber rest.
  • 41:03Three of them within their front comma
  • 41:05and treated them with normal woman.
  • 41:07So in this Co cultures,
  • 41:09if they carry fiberglass,
  • 41:10are processing available mean?
  • 41:11As I I recently showed with Valve woman.
  • 41:15All these diesels with a receptor
  • 41:18for Valve women should be able
  • 41:20to proliferate and we did other
  • 41:23experiments in which we use E.
  • 41:24Coli,
  • 41:25a bacteria that over expresses
  • 41:27about women as well.
  • 41:29And again,
  • 41:29these are the readout of proliferation.
  • 41:31If there is prolific,
  • 41:33there's no proliferation.
  • 41:34These teachers that I label with
  • 41:36CFC will not dilute the die,
  • 41:38so we wouldn't see any peaks any dilution,
  • 41:42but if there is proliferation we will
  • 41:44see this dilution of the membrane dye,
  • 41:47but that's exactly what we saw here,
  • 41:50so this is overwhelming protein.
  • 41:52But here the fiberglass haven't
  • 41:55been treated with interferon gamma,
  • 41:57so they don't express MHC 2.
  • 41:59Very little proliferation,
  • 42:00but here what you can see is that
  • 42:03when they you induce expression
  • 42:04and you treat with over protein,
  • 42:06there is a significant proliferation
  • 42:09of diesel,
  • 42:10suggesting that the fiberglass
  • 42:12can induce diesel proliferation.
  • 42:14And here's a demonstration of
  • 42:16dendritic cells as a positive control,
  • 42:18where we see a proliferation
  • 42:20and as I said before,
  • 42:22these are the professional
  • 42:24antigen presenting cells,
  • 42:25so they don't need to be pre
  • 42:27treated within their from grammar.
  • 42:28They express MHC 2. Constitutively.
  • 42:31We also did these experiments,
  • 42:33obviously with the MMC to knockout.
  • 42:35Correct fiberglass to to show
  • 42:37that this was a specific.
  • 42:41So just to be.
  • 42:44Over a convenience with this
  • 42:47we do particularly proteins.
  • 42:48So instead of putting a
  • 42:50soluble of argument there,
  • 42:52we collaborated with Carolyn Genco and
  • 42:54Robert in our floor in order Department
  • 42:57and they just happen to have these E.
  • 43:00Coli that over expresses,
  • 43:02so we try to correct fiberglass with E.
  • 43:04Coli that had an empty vehicle
  • 43:07or expressing involvement,
  • 43:09and we saw that only when when E.
  • 43:12Coli was expressing about woman we saw.
  • 43:14Diesel is specific for ovum proliferate,
  • 43:17and this is all quantified here,
  • 43:20and this is the positive
  • 43:22control with the sender excels.
  • 43:25So going back to the cardiac pathophysiology,
  • 43:29does this make?
  • 43:30Does this have any effect on correct
  • 43:33dysfunction or cardiac fibrosis?
  • 43:36So in collaboration with Jenn Davies,
  • 43:38the University of Washington,
  • 43:40we obtain the TCF 21 Mercury
  • 43:44Mirror mice decree driver.
  • 43:46Please inducible and we
  • 43:48crushed it with MHC to flux.
  • 43:51And we generated the correct
  • 43:54fiberglass specific deficient in MHC
  • 43:57do and these mice are only deficient
  • 43:59if you treat them with tamoxifen
  • 44:01because it's an inducible line.
  • 44:03So as you can see here,
  • 44:05we corroborated that it when
  • 44:07we treated with tamoxifen,
  • 44:09we decrease the expression of MHC 2.
  • 44:13Here, so this this is what we will be
  • 44:15looking at and we decrease expression.
  • 44:18Incorrect.
  • 44:18Fabulous, but not in bone marrow Dr.
  • 44:20Dendritic cells where MHC 2 levels
  • 44:23remain compatible in the treated
  • 44:26and not treated with oxygen.
  • 44:28And then we looked at fibrosis and as
  • 44:30you can see here there was significant
  • 44:33fibrosis in the TACK control group
  • 44:36than non democracies untreated,
  • 44:38but when we treated with tamoxifen we
  • 44:41reduce fibrosis significantly and this
  • 44:44has an impact in fractional shortening.
  • 44:46So here's that mouse with flattened.
  • 44:50You know contraction here
  • 44:52and this is the most mice,
  • 44:55so again these are the ones that don't
  • 44:58have image do in the fiberglass and
  • 45:01they have preserved systolic function.
  • 45:04So we looked in the lymph nodes
  • 45:07to right because we wanted to
  • 45:09see whether this was where.
  • 45:11Remember that we're eliminating this in
  • 45:14the in the cardiac fibroblast and they
  • 45:17might be other cells that express TCF 21,
  • 45:20although it is,
  • 45:21it was described to be a
  • 45:23driver for collect fibers.
  • 45:24And what we find is that the T cell
  • 45:27immune response in the lymph node
  • 45:29is not altered by by this intact.
  • 45:32And we also see.
  • 45:34Similar infiltration of character
  • 45:36in these mice with tamoxifen.
  • 45:39So working hypothesis now is that
  • 45:42these are the conclusions right that
  • 45:44in these crosstalk we have the T cells
  • 45:48and the fiberglass communicating.
  • 45:50And in this two week crosstalk
  • 45:52we think there correct fibrils
  • 45:53are Sentinel cells that can sense
  • 45:56correct insults and directly boost
  • 45:58the adaptive immune response.
  • 46:00We think that there's a potential of
  • 46:03moderating decent immune responses
  • 46:04without impairing systemic diesel
  • 46:06activation by the cells which could
  • 46:09have undecided major suppressive effect.
  • 46:11So the fact that we see.
  • 46:14Similar activation in the in the
  • 46:16lymph nodes that that tells us to
  • 46:19think that these this is critical in
  • 46:22the heart for the correct fibers.
  • 46:25And then the overall summary,
  • 46:26just to wrap up and leave some time
  • 46:30for questions is that responses.
  • 46:32I think we're pretty convinced with
  • 46:34our work and a lot of the work,
  • 46:36that of others that I've cited and
  • 46:40that we we always site in in our papers,
  • 46:42is the diesel immune responses
  • 46:44contribute to the pathophysiology
  • 46:46of nonischemic heart failure in
  • 46:47many different ways, right?
  • 46:49So we think that eleven took blood pressure,
  • 46:52induces a significant levels of
  • 46:56drugs and the formation of new
  • 46:59antigens that trigger this activation
  • 47:02in the heart. Within that limited repertoire
  • 47:05of those T cells respond to ISO LGS.
  • 47:08Modified cardiac new antigens and contributes
  • 47:11to cardiac fibrosis and dysfunction.
  • 47:13But we don't think these are the early
  • 47:16antigens that diesels are recognizing,
  • 47:18because if you recall from our data,
  • 47:20even when we scavenge those icebergs
  • 47:24modified proteins, we still see
  • 47:26some decent activation in the heart.
  • 47:29So we are doing a lot of more in
  • 47:31depth analysis of single cell.
  • 47:33He's service center sequencing and
  • 47:34trying to get to what are those other
  • 47:37antigens that might be induced response?
  • 47:39And we also see that they're not the same.
  • 47:43Backgrounds overtime,
  • 47:44which might be very relevant to
  • 47:46see how heart failure progresses,
  • 47:48at least pretty nicley.
  • 47:51And then the last conclusion from this
  • 47:53is that these bidirectional actions
  • 47:55between correct resident cells,
  • 47:58in this case fiber rise and T cells
  • 48:01contribute to correct this activation.
  • 48:03My fibrous transformation and
  • 48:05dysfunction under the correct
  • 48:08fabulous expression of MHC 2 molecules
  • 48:11is central for these response.
  • 48:15So with that, I'd like to thank my lab.
  • 48:19I think I've mentioned everyone who's
  • 48:22done the work who's now moved on to new
  • 48:26exciting research leading positions,
  • 48:28and then this is the new members of
  • 48:30the lab that are trying to pick up
  • 48:32on all the good work that previous
  • 48:35former members did in the lab.
  • 48:37Our collaborators at the University
  • 48:38of Washington,
  • 48:39Vanderbilt or collaborators at absent as
  • 48:43Medical Center and our funding sources from.
  • 48:4718 and also from Dallas University.
  • 48:51With that,
  • 48:52I'll be happy to answer questions,
  • 48:54but before that I'll make an announcement
  • 48:56of a very exciting conference,
  • 48:59which will hopefully happen in
  • 49:01person is scheduled to be in person
  • 49:04in Chicago and there will be a
  • 49:06lot of interest in science,
  • 49:07not only in information but a lot of
  • 49:10cardiology and basic and traditional science.
  • 49:14So I'll be happy to take any questions.
  • 49:16Thank you for your time.
  • 49:21Thank you Paula for the wonderful talk.
  • 49:24So now we are open to questions.
  • 49:28I can maybe stop sharing and.
  • 49:33Either way, would you like me?
  • 49:34Or maybe I can leave it open
  • 49:35in case I need to go back to
  • 49:37good? Yeah, good idea Harold, please?
  • 49:40Yeah hi, I really enjoyed the talk.
  • 49:44Wonderful stuff.
  • 49:45A very simplistic question.
  • 49:47So at autopsy when we see
  • 49:49hearts from patients who have
  • 49:52really horrible heart failure.
  • 49:54I don't ever recall seeing a
  • 49:56striking infiltrate of lymphocytes.
  • 49:58Is it that we just get them
  • 49:59at the end stage or or?
  • 50:03I think so compared to other cells
  • 50:05T cells they you don't see massive
  • 50:08infiltration as you would see.
  • 50:10For instance post MI in the
  • 50:12in the in fact zone, right?
  • 50:15And I think I think you don't
  • 50:18need that many of them,
  • 50:20so they're definitely sparse
  • 50:22compared to other major cells.
  • 50:24And then the other thing that I would
  • 50:26say that we've seen when we take
  • 50:28samples from Elbert issue is that
  • 50:30the human heart is very large, right?
  • 50:32So it it also depends where you take
  • 50:36the the piece from, and we've seen.
  • 50:40We've seen some samples that
  • 50:43have more than others.
  • 50:46I don't think it's the timing
  • 50:48because we've done. I mean,
  • 50:50we haven't looked at human hearts early on,
  • 50:52other than those of those healthy,
  • 50:54right, and those have noticed.
  • 50:57But if there was a way to
  • 50:59look inhuman in mice,
  • 51:00you can track that very easily, right?
  • 51:03And one thing that we don't see is that.
  • 51:06And in the chronic phase.
  • 51:08So if you take the mice way longer,
  • 51:10we see that the diesels are more
  • 51:12activated when we use the reporter mice.
  • 51:15But we don't see more details
  • 51:17of our own per say.
  • 51:19So I think that's that's
  • 51:21maybe why inhuman is tricky,
  • 51:23but definitely is not a
  • 51:24dominant cell in the heart.
  • 51:26You have to.
  • 51:27You'll have to find them,
  • 51:29but not being dominant doesn't mean
  • 51:31that they don't do a lot right,
  • 51:34because if they're highly
  • 51:35activated they can release a lot
  • 51:37of factors and do do other things.
  • 51:39But that's a great point, thank you.
  • 51:41Thank you for your question.
  • 51:44I have a question actually 2 questions.
  • 51:49So wonderful talk again.
  • 51:52So do you think this fibroblast
  • 51:57CD4T cell interaction may also
  • 51:59induce macrophage to invade or
  • 52:03activate resident macrophage
  • 52:06to contribute to the fibrosis?
  • 52:09That's the first question.
  • 52:10Second question is related
  • 52:13with hardwood question,
  • 52:14have you considered utilizing
  • 52:17genetic heart failure model such
  • 52:19as meising heavy chain mutation?
  • 52:22Our foes reach you genetic HTM mice
  • 52:25as well as dilated cardiomyopathy like
  • 52:28muscle Lim protein knockout mouse.
  • 52:32They have natural heart failure.
  • 52:34Whether your hack information could
  • 52:36be extended to genetic heart failure,
  • 52:40which may mimic human heart failure
  • 52:42more closely. What do you think?
  • 52:44Yeah, those are two great questions,
  • 52:46so I'll ask for the first one.
  • 52:47The first one, you're totally right.
  • 52:50We've seen that cardiac fibroblast.
  • 52:52Really, ski machines that
  • 52:54not only attract diesels,
  • 52:55but they attract monocytes.
  • 52:58And we we did find that actually
  • 53:02before Sumanth Prabhu had now in
  • 53:05Washington University of Saint Louis.
  • 53:08He found that early on,
  • 53:11and we've corroborated that the Maya
  • 53:14size the CCR 2 positive Milo itself,
  • 53:17so the haematopoietic Lee derived monocytes.
  • 53:20They infiltrate the hard
  • 53:22before the diesels do,
  • 53:24and we found following following up on that,
  • 53:27we found that the correct fiberglass
  • 53:29they make CXCL 9 and 10 that are
  • 53:33chemoattractants for diesels,
  • 53:35but they also make a lot of C, CL two.
  • 53:37So that makes a lot of sense
  • 53:39that when they sense pressure.
  • 53:41And they release the chemo kids.
  • 53:43The second thing in that related
  • 53:46to that question is that.
  • 53:51Once they infiltrate,
  • 53:52so we,
  • 53:53we've found that the major source of the
  • 53:56diesel chemoattractant proteins is not.
  • 53:58The fiberglass is actually the Milo itself.
  • 54:02So those I think it's all orchestrated.
  • 54:05Basically they fibroblasts release
  • 54:07chemo treatments for innate cells.
  • 54:09Then they adapted cells come
  • 54:12because there's also an interaction
  • 54:13between a myeloid cells and the
  • 54:16fibers that we cannot ignore.
  • 54:17I didn't do your second question.
  • 54:19I would love to look at these
  • 54:22models of carry myopathy.
  • 54:25We haven't looked because we we've never.
  • 54:28We don't have the tools or or the mice,
  • 54:31but I would love to to do it because
  • 54:34I think it's it's very important
  • 54:37and especially in those mutations
  • 54:39that the myocytes are are working.
  • 54:42And I did,
  • 54:44at dysfunctional from very early
  • 54:46on it spontaneously right.
  • 54:47You could really track and I'm sure that
  • 54:50there will be other antigens involved, right?
  • 54:53So it might be that we will need to find
  • 54:56out whether inflammation plays a role.
  • 54:58It might be that it has
  • 54:59nothing to do with information,
  • 55:01but if it did, if it did,
  • 55:03it would be easier to track whether the T
  • 55:07cells might be recognizing proteins that are.
  • 55:11You know that may be misfolded,
  • 55:14or that their mutated due to
  • 55:16the mutation in the myocyte,
  • 55:17so that that would be a yeah, that would be.
  • 55:20That's that would be an excellent Ave.
  • 55:23Thank you any other questions?
  • 55:33So yeah, I I,
  • 55:35I'm very excited about the talk.
  • 55:37I have another follow-up question.
  • 55:40What do you think about
  • 55:42stressed cardiomyocytes?
  • 55:44They may release new entity to the
  • 55:48to the identical cells or two so
  • 55:50they they catch up the antigen and
  • 55:53present to CD 4T cells because we
  • 55:56have cardiac troponin T troponin I.
  • 55:58Fragmented release in the injured heart
  • 56:01and and also cardio my side when stressed.
  • 56:05They may secrete teacher
  • 56:07Beta 2 instead of beta one.
  • 56:09We adapt be interesting avenues for you to
  • 56:12yes so that so first hypothesis.
  • 56:15When we started going after the antigen
  • 56:18when J join my lab and he really wanted
  • 56:21to look at this diesel drones right
  • 56:24and our first hypothesis was I had
  • 56:27just written a commentary on a paper.
  • 56:30Looking at all these in altimmune
  • 56:33myocarditis you know how character
  • 56:35planning and myosin binding protein
  • 56:38C and all these proteins that
  • 56:42that are fighting people, right?
  • 56:45So we thought that that that those
  • 56:47who were going to be the ones but
  • 56:50in the tag model because we didn't
  • 56:53see death of Carrie myocytes,
  • 56:55we didn't focus on that.
  • 56:56But you're right, they might be.
  • 56:58They might be that the stretch.
  • 57:00Induces, as you could do that
  • 57:02nicely with your model, right?
  • 57:03Because you can stretch all these cells we.
  • 57:06We don't have the ability to do that,
  • 57:07but I think it's also possible because
  • 57:10the myocytes see the fiberglass
  • 57:12seed in between the myocytes, right?
  • 57:14So there's all these literature that,
  • 57:18and a huge field of research that
  • 57:20people study kind of fiber as
  • 57:23kind of myocyte communication.
  • 57:25So it might be that those fragments
  • 57:28are actually picked up by you?
  • 57:30Know the Mayo side doesn't
  • 57:31really need to die.
  • 57:32It might be that it's a stretch
  • 57:34and the fiber rest pick it up.
  • 57:37And then the fiberglass percent,
  • 57:38but that's purely an in speculation.
  • 57:41We haven't.
  • 57:41We haven't looked at that,
  • 57:44but I think it's not only.
  • 57:46I think this is very complex and
  • 57:48it's not only limited to the
  • 57:50T cell binding to fibroblast.
  • 57:52I think there is a.
  • 57:54Cross communication with like an
  • 57:57orchestrated response there with my
  • 58:00insides fiberglass and immune cells.
  • 58:03Yeah, so we have resident go ahead.
  • 58:07Yeah this is Jeff Squire.
  • 58:10I just wonder you made a comment
  • 58:12on your introduction that said
  • 58:14that no immune intervention.
  • 58:16No trial has produced any
  • 58:18effect on cardiac failure.
  • 58:22And I wonder whether there any
  • 58:24observations in patients who receive.
  • 58:27Chronic immunosuppressive therapy
  • 58:29with any number of different drugs,
  • 58:32whether there's any effect
  • 58:34on cardiac failure.
  • 58:36Yeah, so we did actually have to look at
  • 58:40that because we made a long table of.
  • 58:44Exactly looking at that right of,
  • 58:46you know, these were the TNF blockers
  • 58:49and these are other immunosuppressive
  • 58:51agents and we didn't find any.
  • 58:54I don't think there's been.
  • 58:56There's been a small trials looking at that,
  • 58:59and I think people have looked
  • 59:02at method tracks and other drugs,
  • 59:05but I don't think there's a detail
  • 59:07investigation of what having the
  • 59:09expectation would be that if you
  • 59:11suppress inflammation it be good, right?
  • 59:13But those drugs also have a lot of side
  • 59:17effects that may be in patients with.
  • 59:20Cardiac failure are no quick right,
  • 59:24so I think we really need to dive into
  • 59:27into not blocking inflammation generally
  • 59:32and try to find a smaller pathways.
  • 59:37I certainly agree, but I just
  • 59:39wonder whether there's any
  • 59:40evidence that you know what the
  • 59:42effect of the immune system is
  • 59:44on in clinically and inpatient.
  • 59:46A lot of patients who get,
  • 59:48you know steroids and get
  • 59:50cyclosporine and other.
  • 59:53I I don't recall all the details,
  • 59:55but there is a very elegant review by dogmen.
  • 59:59And Luigi Adamo that they published recently?
  • 01:00:02Maybe? Maybe not.
  • 01:00:03That recently, maybe a year ago in Nature,
  • 01:00:06reviews, cardiology, and they have they.
  • 01:00:09They did exactly that,
  • 01:00:11and they reviewed all the literature
  • 01:00:14in large trials, small trials,
  • 01:00:16directly tackling immune mediators,
  • 01:00:20or general immuno suppressors. And I,
  • 01:00:23I recall that the conclusion is what I said,
  • 01:00:26but maybe you know, maybe I mean.
  • 01:00:29But I. I think yes, if you have time.
  • 01:00:32That review was very detailed and it was.
  • 01:00:35It was very nice to to read and they had the
  • 01:00:38they reviewed the mechanistic part of it,
  • 01:00:40but then they review all the patient trials.
  • 01:00:43At the end.
  • 01:00:45I believe it was in nature reviews,
  • 01:00:47cardiology for sure and I don't
  • 01:00:49know if it was 2020 or 2021.
  • 01:00:52But
  • 01:00:53thank you yeah. Yeah.
  • 01:00:59So if if there are no additional
  • 01:01:01questions so thank you so much
  • 01:01:04Paula for this exciting talk.
  • 01:01:05We learn a lot cardiology immunology,
  • 01:01:08so thank you very much.
  • 01:01:09Have a nice afternoon.
  • 01:01:11Thank you for the invitation.
  • 01:01:13I thank you all for attending bye.
  • 01:01:15Bye bye thank you.